FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

The FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited (ANDA 076900).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Atenolol (Atenolol)

Snippet

SUPPL AP for ATENOLOL (ATENOLOL)